Research map: Distribution and Characteristics of Vaccine Adverse Events: Analysis of Over 2 Million Individual Case Safety Reports

Back to the article

Papers in this map

  1. Safety Monitoring of COVID ‐19 Vaccines: Perspective from the European Medicines Agency · Julie Durand · 2022 · 42 citations · Cited by this paper
  2. Real-World Evaluation of a Pneumonia PCR Panel: Appropriateness, Outcomes, and Antimicrobial Stewardship Implications · 2025 · Related
  3. Overview of U.S. COVID-19 vaccine safety surveillance systems · Julianne M. Gee · 2024 · 27 citations · Cited by this paper
  4. Characterization of Electronic Missing Medication Requests to Identify Medication-Use System Vulnerabilities and Interprofessional Workflow Targets · 2026 · Related
  5. Time for action: towards an intersectional gender approach to COVID-19 vaccine development and deployment that leaves no one behind · Shirin Heidari · 2021 · 26 citations · Cited by this paper
  6. Effects of Telepharmacy in Post Ischemic Stroke Patients: A Randomized Controlled Trial · 2026 · Related
  7. An Overview of COVID-19 Vaccine Safety and Post-marketing Surveillance Systems · Manal M. Younus · 2021 · 13 citations · Cited by this paper
  8. Drug-Related Problems in Outpatient Prescriptions Across Different Levels of Care in Vietnam: A Multicentre Cross-Sectional Study in a Resource-Constrained Health System · 2026 · Related
  9. Real-World Monitoring of COVID-19 Vaccines: An Industry Expert View on the Successes, Challenges, and Future Opportunities · Vincent Bauchau · 2023 · 11 citations · Cited by this paper
  10. Hypotensive Events Associated With PDE-5 Inhibitors in Pulmonary Arterial Hypertension: Assessment of the USFDA Adverse Event Reporting System Using Disproportionality and Interaction Analysis · 2026 · Related
  11. Utility and limitations of the FDA adverse events reporting system public dashboard for safety analyses: a case study with vesicular monoamine transporter 2 inhibitors · Roger S. McIntyre · 2025 · 9 citations · Cited by this paper
  12. Identifying and Resolving Drug-Related Problems in Geriatric Patients · 2026 · Related
  13. Vaccine safety surveillance in South Africa through COVID-19: A journey to systems strengthening · Chenoa Sankar · 2024 · 9 citations · Cited by this paper
  14. Probable Tirzepatide-Induced Rhabdomyolysis in an HIV-Positive Patient · 2026 · Related
  15. National Pharmacovigilance Assessment of Oral Adverse Events Following COVID-19 Vaccination in Germany (2020-2023) · Abanoub Riad · 2025 · 4 citations · Cited by this paper
  16. Impact of Peripheral Rabbit Anti-Thymocyte Globulin Without Heparin and Hydrocortisone Additives on Local Infusion Reactions · 2026 · Related
  17. Sex, Age, and COVID-19 Vaccine Characteristics Associated with Adverse Events After Vaccination and Severity: A Retrospective Analysis · Edgar Paolo Rodríguez Vidales · 2025 · 4 citations · Cited by this paper
  18. Significant Published Articles in 2025 for Pharmacy Nutrition Support Practice · 2026 · Related
  19. Monitoring Vaccine Safety: United States Vaccine Safety Surveillance Systems · Lauren Head Zauche · 2025 · 4 citations · Cited by this paper
  20. Feasibility of cohort event monitoring and assessment of reactogenicity and adverse events among a cohort of AstraZeneca and Moderna COVID-19 vaccine recipients in Nigeria, 2021 · Omotayo O. Bolu · 2025 · 2 citations · Cited by this paper
  21. Surveillance of adverse events following immunisation in Australia annual report, COVID-19 vaccines, 2022 · Yuanfei Anny Huang · 2025 · 2 citations · Cited by this paper
  22. Safety Profile of COVID-19 Vaccines: Retrospective Analysis of Short, Medium, and Long-Term Side Effects: The Military Hospital Experience · Antonio Sabba · 2025 · 1 citation · Cited by this paper
  23. Clinical adverse events following COVID-19 vaccination: a scoping review of observational studies · Carlos Andres Chango Rodríguez · 2025 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)